CMS certification 330059
Montefiore Medical Center
111 East 210th Street, Bronx, NY 10467
Montefiore Medical Center has a CMS overall rating of 3 out of 5 stars. 65% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 8 and worse on 4. Emergency patients spend a median of 3 h 13 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 4,904 completed surveys, 11% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NY | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 408 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 13 min | 3 h 14 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 16 visits sampled | 12 h 26 min | 4 h 54 min | 4 h 17 min |
| Left before being seen Lower is better · 305,503 patients | 1% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 142 patients | 20% | 60% | 65% |
How Montefiore Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Montefiore Medical CenterThis hospital | 3/5 | 65% | 3 h 13 min | 8 better 4 worse |
| Bronx VA Medical CenterSame city | 4/5 | 71% | — | 1 worse |
| Jacobi Medical CenterSame city | 2/5 | 61% | 3 h 40 min | 2 better 2 worse |
| St Barnabas HospitalSame city | 1/5 | 55% | 5 h 1 min | 2 better 2 worse |
| Bronxcare Hospital CenterSame city | 1/5 | 56% | 3 h 6 min | 3 worse |
| Lincoln Medical & Mental Health CenterSame city | 2/5 | 52% | 3 h 54 min | 2 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Bronx.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 13,803 cases | Too few cases | 2.4% | 3.9% |
| Heart attack 235 cases | Too few cases | 10.9% | 11.9% |
| Heart failure 726 cases | Too few cases | 5.2% | 11.1% |
| Pneumonia 878 cases | Too few cases | 9.2% | 15.2% |
| Stroke 1,164 cases | Too few cases | 7.5% | 11.9% |
| COPD 228 cases | Too few cases | 7% | 8.6% |
| Heart bypass surgery (CABG) 71 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Worse | 1.23 likely 1.01 – 1.45 | 1 |
| After hip or knee replacement 1,424 cases | Too few cases | 2.8% | 4.1% |
| Deaths after a serious but treatable surgical complication 293 cases | No different | 173.71 per 1,000 likely 144.1 per 1,000 – 203.32 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 17,685 cases | Worse | 0.95 per 1,000 likely 0.64 per 1,000 – 1.26 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 18,946 cases | No different | 0.1 per 1,000 likely 0 per 1,000 – 0.26 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 20,155 cases | No different | 0.21 per 1,000 likely 0.05 per 1,000 – 0.36 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,435 cases | No different | 2.47 per 1,000 likely 1.29 per 1,000 – 3.65 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,159 cases | No different | 1.42 per 1,000 likely 0.03 per 1,000 – 2.82 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,120 cases | No different | 10.77 per 1,000 likely 5.48 per 1,000 – 16.06 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,522 cases | Worse | 5.96 per 1,000 likely 4.4 per 1,000 – 7.52 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,192 cases | No different | 6.47 per 1,000 likely 3.29 per 1,000 – 9.65 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 744 cases | No different | 1.92 per 1,000 likely 0.57 per 1,000 – 3.28 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,839 cases | No different | 0.7 per 1,000 likely 0 per 1,000 – 1.48 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.58 likely 0.41 – 0.81 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.68 likely 0.46 – 0.96 | 1 |
| Surgical site infections after colon surgery | No different | 1.06 likely 0.57 – 1.8 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.34 likely 0.34 – 3.64 | 1 |
| MRSA bloodstream infections | No different | 0.81 likely 0.56 – 1.14 | 1 |
| C. diff intestinal infections | Better | 0.28 likely 0.22 – 0.36 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 722 cases | Too few cases | 17.8% | 14.4% |
| Readmitted after heart failure 2,620 cases | Too few cases | 21.8% | 21.3% |
| Readmitted after pneumonia 2,180 cases | Too few cases | 18.7% | 17.3% |
| Readmitted after COPD 973 cases | Too few cases | 22.3% | 20% |
| Readmitted after heart bypass surgery 170 cases | Too few cases | 12.9% | 11% |
| Readmitted after hip or knee replacement 1,427 cases | Too few cases | 5.2% | 5.8% |
| Days back in hospital after a heart attack 255 cases | Too few cases | 22 days per 100 | — |
| Days back in hospital after heart failure 840 cases | Too few cases | -18 days per 100 | — |
| Days back in hospital after pneumonia 886 cases | Too few cases | -6.4 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 803 cases | No different | 12.3 per 1,000 likely 9.3 per 1,000 – 16.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 356 cases | No different | 13.2 per 100 likely 10.5 per 100 – 16.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 356 cases | No different | 4.1 per 100 likely 2.8 per 100 – 5.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 627 cases | No different | 0.8 likely 0.6 – 1.1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
1,523 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 1,591 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Physician Assistant | 185 |
| Internal Medicine | 103 |
| Anesthesiology | 89 |
| Pediatrics | 77 |
| Family | 73 |
| Medical | 59 |
| Pharmacist | 52 |
| Emergency Medicine | 50 |
| General Practice | 38 |
| Clinical | 37 |
| Surgical | 34 |
| Psychiatry | 32 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $14.3M
- 2020 $12.3M
- 2021 $9.1M
- 2022 $13.5M
- 2023 $7M
- 2024 $6M
- 2025 $7.2M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $4.9M | 206 |
| Speaking, teaching and other services | $209,325 | 68 |
| Space rental and facility fees | $162,250 | 48 |
| Education | $121,500 | 6 |
| Medical devices and supplies on long-term loan | $84,533 | 18 |
| Charitable contributions | $11,000 | 3 |
| Gifts | $9,057 | 3 |
| Debt forgiveness | $3,008 | 17 |
| Food and beverage | $100 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Abbvie INC. | $792,245 | 145 |
| Genentech, Inc. | $697,613 | 8 |
| Pfizer INC. | $668,886 | 10 |
| Merck Sharp & Dohme LLC | $551,835 | 8 |
| Regeneron Pharmaceuticals, Inc. | $509,142 | 4 |
| Solventum Corporation | $397,116 | 1 |
| Novartis Pharmaceuticals Corporation | $343,946 | 21 |
| Takeda Pharmaceuticals U.S.A., Inc. | $326,570 | 6 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer Regeneron Pharmaceuticals, Inc. | $308,142 |
| Beamion LUNG-2: A Phase III, open-label, randomised, active-controlled, multi-centre trial evaluating orally administered BI 1810631 compared to stan… Boehringer Ingelheim Pharma GmbH & Co.KG | $160,777 |
| Real World Use of Emicizumab in infants and children 0 36 months old Genentech, Inc. | $119,924 |
| Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence… Blue Earth Diagnostics · NCT06604442 | $110,430 |
| A phase 1b/2 study of neoadjuvant nivolumab, chemotherapy, and sub-ablative stereotactic body radiation therapy for resectable lymph node positive st… E.R. Squibb & Sons, L.L.C. | $108,042 |
| A PHASE 3 RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF PF06821497 MEVROMETOSTAT WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE … PFIZER INC. | $77,013 |
| Elimination through Evaluation of Jail-based Peer Transitional Navigation The ELEVATION Study Gilead Sciences, Inc. | $73,259 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Dose-finding Phase 2b Study to Investigate the Safety and Effi… Novartis Pharmaceuticals Corporation | $72,278 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Montefiore Medical Center
Is Montefiore Medical Center a good hospital?
Montefiore Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 8 and worse on 4. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Montefiore Medical Center?
65% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 4,904 completed HCAHPS surveys.
How long is the wait in the Montefiore Medical Center emergency room?
Emergency patients spend a median of 3 h 13 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Montefiore Medical Center receive money from drug and device companies?
Drug and device makers reported $7.2M in payments to Montefiore Medical Center for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.